The latest news in cancer research

  • All
  • Events
  • General
  • Patient Stories
  • Quality Assurance
  • Trial publications
  • Trials
  • TROG Members
  • TROG Supporters
cancer research news, TROG Cancer Research News, TROG Cancer Research
Trial publications

TROG trials in the spotlight at ESTRO26 international conference

LATEST NEWS: 20 MAY A number of TROG trials and projects garnered international attention this month, as researchers presented findings at one of the world’s ...
Read More →
cancer research news, TROG Cancer Research News, TROG Cancer Research
Trial publications

FASTRACK II trial finds emerging radiotherapy technique effectively controls kidney cancer

LATEST NEWS: 18 MAY 2026 A new non-invasive form of radiation therapy achieves unprecedented 100% effectiveness in treating primary kidney cancers, findings from the world-leading ...
Read More →
cancer research news, TROG Cancer Research News, TROG Cancer Research
Quality Assurance

Review highlights vital need for RTQA in radiation therapy research

LATEST NEWS: 14 May 2026 The need for greater focus on radiation therapy quality assurance (RTQA) in clinical trials has been highlighted by a recent ...
Read More →
cancer research news, TROG Cancer Research News, TROG Cancer Research
TROG Supporters

Consumer Engagement Charter cements TROG’s commitment to listen to consumer voices

LATEST NEWS: 14 April 2026 TROG has made a commitment to involving consumer voices in all aspects of our work, from research strategy through to ...
Read More →
cancer research news, TROG Cancer Research News, TROG Cancer Research
TROG Members

Vale Professor Jim Denham OAM, TROG founder and world-class researcher

9 April 2026 TROG Cancer Research honours the life and legacy of Radiation Oncologist Professor Jim Denham OAM, a founding member and pioneering researcher whose ...
Read More →
cancer research news, TROG Cancer Research News, TROG Cancer Research
Trials

TROG Secondary Data Analysis Grant awarded to project to better understand prostate cancer therapy outcomes

LATEST NEWS: 31 March 2026 TROG’s inaugural Secondary Data Analysis (SDA) grant has been awarded to an early-career researcher who will draw on data from ...
Read More →
cancer research news, TROG Cancer Research News, TROG Cancer Research
Events

TROG welcomes new Board members and President-Elect

LATEST NEWS: 26 March 2026 We are delighted to announce the appointment of a new President-Elect as well as two new Elected Directors to the ...
Read More →
cancer research news, TROG Cancer Research News, TROG Cancer Research
Events

TROG’S 38th ASM puts focus on driving innovative trials

LATEST NEWS: 26 March 2026 TROG’s 2026 Annual Scientific Meeting (ASM) paved the way for innovative future research, exploring vital issues ranging from boosting consumer ...
Read More →
cancer research news, TROG Cancer Research News, TROG Cancer Research
Events

The ‘TROGIES’ 2026: Celebrating our Members’ research achievements

LATEST NEWS: 25 March 2026 TROG Cancer Research proudly celebrated the outstanding contributions of its members at our 2026 Research Excellence Awards (the ‘TROGIES’) this ...
Read More →
cancer research news, TROG Cancer Research News, TROG Cancer Research
Trials

First patient recruited for trial of new imaging modality for lung cancer

LATEST NEWS: 24 February 2026 The first Australian participant has been recruited to take part in an innovative trial that could mark a shift in ...
Read More →
cancer research news, TROG Cancer Research News, TROG Cancer Research
Patient Stories

Roland’s story

Roland TowningPort Stephens, NSW Roland Towning is taking part in the TROG 18.01 NINJA trial which is comparing the effectiveness of two different radiation therapy ...
Read More →
cancer research news, TROG Cancer Research News, TROG Cancer Research
Quality Assurance

New guidelines developed by TROG for clinical trial use of stereotactic radiosurgery for brain metastases

LATEST NEWS: 27 January 2026 New guidelines to ensure accuracy and quality in clinical trials using stereotactic radiosurgery (SRS) to treat brain metastases have been ...
Read More →